Balaxi Pharmaceuticals Nil Physical Share Transfer Re-Lodgement

Date: 11th November, 2026

Regulatory Compliance Disclosure

Balaxi Pharmaceuticals Limited submitted a regulatory compliance report to the National Stock Exchange of India Limited regarding physical share transfer re-lodgement requests as mandated by SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 dated 30th January, 2026.

The report covers the period ended October 2026 and was prepared by the company's Registrar and Share Transfer Agent, M/s. Aarthi Consultants Private Limited.

Physical Share Transfer Re-Lodgement Status (October 2026)

• Number of requests received during the month: NIL
• Number of requests processed during the month: NIL
• Number of requests approved during the month: NIL
• Number of requests rejected during the month: NIL
• Average time taken for processing of requests: NA

No material disclosures under the following sections:

• KMP / Board / Auditor Changes
• Dividend Declaration or Non-Declaration
• Board Meeting Outcomes
• Financial Results
• Auditor's Report
• Disinvestment / Strategic Actions
• Media Release / Investor Communication
• Other Operational / Legal / Strategic Disclosures